Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair

Annals of Vascular Surgery

Volumn 20, Issue 5, 2006, Pages 569-576

  Kurzencwyg, David ^a   Filion, Kristian B ^a   Pilote, Louise ^b   Nault, Patrice ^c   Platt, Robert W ^d   Rahme, Elham ^b   Steinmetz, Oren ^e   Eisenberg, Mark J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; LISINOPRIL; METOPROLOL; MEVINOLIN; SIMVASTATIN;

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM SURGERY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DRUG USE; FEMALE; GROUPS BY AGE; HEART PROTECTION; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 33845614868     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-006-9078-z     Document Type: Article

References (29)

1. Dillavou ED, Muluk SC, Makaroun MS. Improving aneurysm-related outcomes: nationwide benefits of endovascular repair. J Vasc Surg 2006;43:446-451.
2. Dimick JB, Stanley JC, Axelrod DA, et al. Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg 2002;235:579-585.
3. Mukai S, Yao H, Miyamoto T, et al. The long-term follow-up results of elective surgical treatment for abdominal aortic aneurysms. Ann Thorac Cardiovasc Surg 2002;8:38-41.
4. Bayazit M, Gol MK, Battaloglu B, et al. Routine coronary arteriography before abdominal aortic aneurysm repair. Am J Surg 1995;170:246-250.
5. Sasaki Y, Isobe F, Kinugasa S, et al. Influence of coronary artery disease on operative mortality and long-term survival after abdominal aortic aneurysm repair. Surg Today 2004;34:313-317.
6. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-1794.
7. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-1720.
8. Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001;141:148-153.
9. De Hert S, Foubert L, Poelaert J, et al. Beta-adrenergic blocking drugs in the perioperative period. Acta Anaesthesiol Belg 2003;54:127-139.
10. Prasad A, Mincemoyer R, Quyyumi AA. Anti-ischemic effects of angiotensin-converting enzyme inhibition in hypertension. J Am Coll Cardiol 2001;38:1116-1122.
11. Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1997;96:2751-2753.
12. Alber HF, Dulak J, Frick M, et al. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. J Am Coll Cardiol 2002;39:1951-1955.
13. U.S. Department of Health and Human Services. Generic ICD-9-CM, Hospital Version 2001. Reno, NV: Channel Publishing, 2000.
14. Harrington RA, Becker RC, Ezekowitz M, et al. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl 3):513S-548S.
15. Muhlestin JB. Post-hospitalization management of high-risk coronary patients. Am J Cardiol 2000;85:13B-20B.
16. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 2004;292:1867-1874.
17. Hackam DG, Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease. Semin Vasc Med 2003;3:323-332.
18. Sleight P, Yusuf S. New evidence on the importance of the renin-angiotensin system in the treatment of higher-risk patients with hypertension. J Hypertens 2003;21:1599-1608.
19. Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation 1998;97:1411-1420.
20. Kjoller-Hansen L, Steffensen R, Grande P. The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experience. Scand Cardiovasc J 1998;32:225-232.
21. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigators. N Engl J Med 2000;342:145-153.
22. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107:1848-1851.
23. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004;291:2092-2099.
24. Devereaux PJ, Yusuf S, Yang H, et al. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?. CMAJ 2004;171:245-247.
25. Rapchuk I, Rabuka S, Tonelli M. Perioperative use of beta-blockers remains low: experience of a single Canadian tertiary institution. Can J Anaesth 2004;51:761-767.
26. VanDenKerkhof EG, Milne B, Parlow JL. Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of Canadian anesthesiologists. Anesth Analg 2003;96:1558-1565.
27. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-361.
28. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001;93:573-580.
29. Eisenberg MJ, Okrainec K, Lefkovits J, et al. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry. Can J Cardiol 2003;19:1009-1015.